Tianda Pharmaceuticals Limited (HKG:0455)
Hong Kong · Delayed Price · Currency is HKD 0.0930
+0.0070 (8.14%)
Jun 1, 2026, 1:20 PM HKT
Tianda Pharmaceuticals Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Mar '22 Mar 31, 2022 |
Net Income | -70 | -61.37 | -24.16 | -54.64 | -19.77 |
Depreciation & Amortization | 36.21 | 36.28 | 34.47 | 48.25 | 20.03 |
Other Amortization | 2.45 | 1.95 | 1.94 | 2 | 2.12 |
Loss (Gain) From Sale of Assets | 0.11 | 0.1 | -0.14 | -1.25 | -12.03 |
Asset Writedown & Restructuring Costs | 14.76 | 1.34 | - | - | 1.58 |
Loss (Gain) From Sale of Investments | - | - | - | 0.12 | 0.02 |
Loss (Gain) on Equity Investments | 0.26 | - | - | - | - |
Provision & Write-off of Bad Debts | -0.02 | -0.6 | 0.79 | 0.62 | 0.44 |
Other Operating Activities | -0.21 | -2.16 | -4.68 | -7.07 | -20.04 |
Change in Accounts Receivable | 4.4 | 26 | 33.31 | -14.63 | 9.08 |
Change in Inventory | -1.94 | 23.5 | -18.9 | 19.23 | -8.68 |
Change in Accounts Payable | 16.74 | 4.85 | 35.48 | -32.97 | 13.41 |
Change in Other Net Operating Assets | 11.27 | -39.6 | -107.86 | 142.23 | 5.62 |
Operating Cash Flow | 14.04 | -9.7 | -49.76 | 101.9 | -8.23 |
Capital Expenditures | -6.86 | -20.61 | -49.28 | -33.28 | -53.76 |
Sale of Property, Plant & Equipment | - | 0.09 | 0.28 | 1.63 | 0.03 |
Divestitures | - | - | - | - | 151.9 |
Sale (Purchase) of Intangibles | -8.99 | -16.88 | -17 | - | - |
Investment in Securities | -4.68 | -10.86 | -6.14 | 14.49 | -13.77 |
Other Investing Activities | 0.38 | 16.48 | 3.03 | 4.34 | 1.95 |
Investing Cash Flow | -20.14 | -31.78 | -69.1 | -12.81 | 86.35 |
Long-Term Debt Issued | 113.38 | 75.92 | 43.46 | - | 33.46 |
Total Debt Issued | 113.38 | 75.92 | 43.46 | 21.54 | 33.46 |
Long-Term Debt Repaid | -129.46 | -100.98 | -70.03 | - | -25.31 |
Total Debt Repaid | -129.46 | -100.98 | -70.03 | -36.68 | -25.31 |
Net Debt Issued (Repaid) | -16.09 | -25.06 | -26.58 | -15.14 | 8.15 |
Issuance of Common Stock | 0.15 | - | - | - | - |
Common Dividends Paid | - | -5.59 | -5.59 | -23.5 | -8.56 |
Other Financing Activities | 0.78 | - | -25.23 | 0.12 | -0.89 |
Financing Cash Flow | -15.16 | -30.65 | -57.39 | -38.52 | -1.3 |
Foreign Exchange Rate Adjustments | 0.39 | -4.63 | -1.58 | -42.21 | 8.93 |
Net Cash Flow | -20.88 | -76.75 | -177.84 | 8.37 | 85.76 |
Free Cash Flow | 7.18 | -30.3 | -99.04 | 68.63 | -61.98 |
Free Cash Flow Margin | 2.22% | -9.18% | -18.61% | 12.55% | -12.16% |
Free Cash Flow Per Share | 0.00 | -0.01 | -0.05 | 0.03 | -0.03 |
Cash Interest Paid | 3.53 | 4.85 | 4.95 | 6.72 | - |
Cash Income Tax Paid | -0.26 | 5.96 | -0.37 | 0.41 | - |
Levered Free Cash Flow | 9.51 | -71.25 | -112.42 | - | 101.92 |
Unlevered Free Cash Flow | 11.72 | -68.22 | -109.33 | - | 102.37 |
Change in Working Capital | 30.47 | 14.76 | -57.97 | 113.86 | 19.43 |